Prevalence of faecal carriage of NDM-1-producing bacteria among patients with diarrhoea in Bangladesh

References

1. Day K. M., Salman M., Kazi B., Sidjabat H. E., Silvey A., Lanyon C. V., Cummings S. P., Ali M. N., Raza M. W.& other authors ( 2013; Prevalence of NDM-1 carbapenemase in patients with diarrhoea in Pakistan and evaluation of two chromogenic culture media. J Appl Microbiol 114:1810–1816 [View Article][PubMed]
   [Google Scholar]
2. Islam M. A., Talukdar P. K., Hoque A., Huq M., Nabi A., Ahmed D., Talukder K. A., Pietroni M. A., Hays J. P.& other authors ( 2012; Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh. Eur J Clin Microbiol Infect Dis 31:2593–2600 [View Article][PubMed]
   [Google Scholar]
3. Islam M. A., Huq M., Nabi A., Talukdar P. K., Ahmed D., Talukder K. A., Cravioto A., Endtz H. P. 2013; Occurrence and characterization of multidrug-resistant New Delhi metallo-β-lactamase-1-producing bacteria isolated between 2003 and 2010 in Bangladesh. J Med Microbiol 62:62–68 [View Article][PubMed]
   [Google Scholar]
4. Johnson A. P., Woodford N. 2013; Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 62:499–513 [View Article][PubMed]
   [Google Scholar]
5. Perry J. D., Naqvi S. H., Mirza I. A., Alizai S. A., Hussain A., Ghirardi S., Orenga S., Wilkinson K., Woodford N.& other authors ( 2011; Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother 66:2288–2294 [View Article][PubMed]
   [Google Scholar]
6. Sykes R. 2010; The 2009 Garrod Lecture: the evolution of antimicrobial resistance: a Darwinian perspective. J Antimicrob Chemother 65:1842–1852 [View Article][PubMed]
   [Google Scholar]
7. Walsh T. R., Weeks J., Livermore D. M., Toleman M. A. 2011; Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 11:355–362 [View Article][PubMed]
   [Google Scholar]